S&P 500   3,952.95 (-1.25%)
DOW   32,129.32 (-1.32%)
QQQ   312.09 (+0.56%)
AAPL   159.54 (+0.16%)
MSFT   275.90 (+0.77%)
META   203.27 (+0.55%)
GOOGL   105.15 (+0.22%)
AMZN   100.21 (-0.40%)
TSLA   194.64 (-1.49%)
NVDA   270.17 (+3.12%)
NIO   9.23 (-0.43%)
BABA   84.28 (+0.69%)
AMD   99.06 (+3.26%)
T   18.54 (+0.00%)
F   11.68 (-0.34%)
MU   59.02 (+0.67%)
CGC   1.92 (-2.79%)
GE   90.81 (-1.49%)
DIS   96.20 (-0.35%)
AMC   4.52 (+2.49%)
PFE   40.25 (-1.01%)
PYPL   75.39 (-1.73%)
NFLX   298.36 (-2.43%)
S&P 500   3,952.95 (-1.25%)
DOW   32,129.32 (-1.32%)
QQQ   312.09 (+0.56%)
AAPL   159.54 (+0.16%)
MSFT   275.90 (+0.77%)
META   203.27 (+0.55%)
GOOGL   105.15 (+0.22%)
AMZN   100.21 (-0.40%)
TSLA   194.64 (-1.49%)
NVDA   270.17 (+3.12%)
NIO   9.23 (-0.43%)
BABA   84.28 (+0.69%)
AMD   99.06 (+3.26%)
T   18.54 (+0.00%)
F   11.68 (-0.34%)
MU   59.02 (+0.67%)
CGC   1.92 (-2.79%)
GE   90.81 (-1.49%)
DIS   96.20 (-0.35%)
AMC   4.52 (+2.49%)
PFE   40.25 (-1.01%)
PYPL   75.39 (-1.73%)
NFLX   298.36 (-2.43%)
S&P 500   3,952.95 (-1.25%)
DOW   32,129.32 (-1.32%)
QQQ   312.09 (+0.56%)
AAPL   159.54 (+0.16%)
MSFT   275.90 (+0.77%)
META   203.27 (+0.55%)
GOOGL   105.15 (+0.22%)
AMZN   100.21 (-0.40%)
TSLA   194.64 (-1.49%)
NVDA   270.17 (+3.12%)
NIO   9.23 (-0.43%)
BABA   84.28 (+0.69%)
AMD   99.06 (+3.26%)
T   18.54 (+0.00%)
F   11.68 (-0.34%)
MU   59.02 (+0.67%)
CGC   1.92 (-2.79%)
GE   90.81 (-1.49%)
DIS   96.20 (-0.35%)
AMC   4.52 (+2.49%)
PFE   40.25 (-1.01%)
PYPL   75.39 (-1.73%)
NFLX   298.36 (-2.43%)
S&P 500   3,952.95 (-1.25%)
DOW   32,129.32 (-1.32%)
QQQ   312.09 (+0.56%)
AAPL   159.54 (+0.16%)
MSFT   275.90 (+0.77%)
META   203.27 (+0.55%)
GOOGL   105.15 (+0.22%)
AMZN   100.21 (-0.40%)
TSLA   194.64 (-1.49%)
NVDA   270.17 (+3.12%)
NIO   9.23 (-0.43%)
BABA   84.28 (+0.69%)
AMD   99.06 (+3.26%)
T   18.54 (+0.00%)
F   11.68 (-0.34%)
MU   59.02 (+0.67%)
CGC   1.92 (-2.79%)
GE   90.81 (-1.49%)
DIS   96.20 (-0.35%)
AMC   4.52 (+2.49%)
PFE   40.25 (-1.01%)
PYPL   75.39 (-1.73%)
NFLX   298.36 (-2.43%)
LON:HLN

Haleon - HLN Share Forecast, Price & News

GBX 328.85
+5.10 (+1.58%)
(As of 03/22/2023 04:45 PM ET)
Add
Compare
Today's Range
324.20
▼
330.70
50-Day Range
310.10
▼
336
52-Week Range
241.17
▼
337.95
Volume
12.24 million shs
Average Volume
13.67 million shs
Market Capitalization
£30.35 billion
P/E Ratio
2,989.55
Dividend Yield
1.52%
Price Target
GBX 331.56

Haleon MarketRank™ Forecast

Analyst Rating
Hold
2.22 Rating Score
Upside/​Downside
1.8% Downside
GBX 323.09 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.95 out of 5 stars

See Top Rated MarketRank™ Stocks Here

HLN stock logo

About Haleon (LON:HLN) Stock

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

HLN Stock News Headlines

March 5, 2023 | msn.com
UK stocks to buy amid a cost-of-living crisis!
March 5, 2023 | finance.yahoo.com
Haleon plc Just Missed Earnings - But Analysts Have Updated Their Models
March 22, 2023 | Legacy Research (Affiliate) (Ad)
"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast
March 2, 2023 | finance.yahoo.com
Haleon PLC Announces Redemption of US$300,000,000 Outstanding Notes
February 22, 2023 | msn.com
These 3 top banks think the Haleon share price will rally. What should I do?
February 8, 2023 | reuters.com
HLN.L - | Stock Price & Latest News | Reuters
February 1, 2023 | reuters.com
Analysis: GSK gives few clues on plans to replenish medicine cabinet
February 1, 2023 | proactiveinvestors.com
Haleon's reported strategic M&A dismissed as 'highly unlikely' and unwanted headache
March 22, 2023 | Legacy Research (Affiliate) (Ad)
"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast
January 31, 2023 | seekingalpha.com
Haleon: A Great Consumer Staples Add
January 20, 2023 | seekingalpha.com
Successful Data Analysis Could Be Game Changer For Haleon
December 24, 2022 | finance.yahoo.com
Haleon plc (LON:HLN) Delivered A Weaker ROE Than Its Industry
December 13, 2022 | msn.com
The Haleon share price is back near where it started. Should I buy the stock now?
December 7, 2022 | proactiveinvestors.com
Haleon upgraded by Barclays after Zantac litigation dismissed
December 6, 2022 | seekingalpha.com
Why did Sanofi stock Jump up today? Zantac litigation tossed out by judge
December 6, 2022 | finance.yahoo.com
Should You Add Haleon plc (HLN) to Your Portfolio?
December 2, 2022 | finance.yahoo.com
Is Haleon plc (HLN) a Good Investment Avenue?
November 30, 2022 | seekingalpha.com
Tracking Kahn Brothers Portfolio - Q3 2022 Update
November 26, 2022 | seekingalpha.com
Haleon's Dilemma: To Wait Or Not To Wait
November 11, 2022 | finance.yahoo.com
Here’s What Makes Haleon (HLN) an Attractive Investment Pick
November 10, 2022 | msn.com
Haleon hits 3-month high after raising full-year profit outlook
November 10, 2022 | msn.com
Former GSK consumer health arm Haleon posts 16.1% jump in quarterly sales
November 10, 2022 | proactiveinvestors.com
Haleon hikes organic revenue guidance after sustained price increases
November 2, 2022 | proactiveinvestors.com
Haleon third-quarter update is big date for Pfizer stock overhang
October 31, 2022 | finance.yahoo.com
Haleon plc Announces Expiration and Results of Exchange Offers for Certain Series of Notes Issued in Private Placements in Connection with the Separation from GSK
October 11, 2022 | proactiveinvestors.com
Barclays analysts impressed by Haleon sales targets
September 29, 2022 | finance.yahoo.com
Haleon plc Announces Exchange Offers for Certain Series of Notes Issued in Private Placements in Connection with the Separation from GSK
See More Headlines
Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

HLN Company Calendar

Ex-Dividend for 4/27 Dividend
3/16/2023
Today
3/22/2023
Dividend Payable
4/27/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
LON:HLN
CUSIP
N/A
CIK
N/A
Web
www.haleon.com
Phone
44 1932 822000
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 323.09
High Stock Price Forecast
GBX 376
Low Stock Price Forecast
GBX 250
Forecasted Upside/Downside
+1.3%
Consensus Rating
Hold
Rating Score (0-4)
2.22
Research Coverage
9 Analysts

Profitability

EPS (Most Recent Fiscal Year)
GBX 0.11
Trailing P/E Ratio
2,975.45
Forward P/E Ratio
18.21
P/E Growth
2.52
Net Income
£1.06 billion
Net Margins
9.76%
Pretax Margin
N/A
Return on Equity
5.21%
Return on Assets
4.30%

Debt

Debt-to-Equity Ratio
64.50
Current Ratio
0.93
Quick Ratio
0.93

Sales & Book Value

Annual Sales
£10.86 billion
Price / Sales
2.78
Cash Flow
GBX 14.91 per share
Price / Cash Flow
21.95
Book Value
GBX 177 per share
Price / Book
1.85

Miscellaneous

Outstanding Shares
9,230,000,000
Free Float
N/A
Market Cap
£30.21 billion
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Brian McNamara (Age 56)
    CEO & Exec. Director
  • Mr. Tobias Hestler (Age 51)
    CFO & Exec. Director
  • Ms. Amy Landucci
    Head of Digital and Technology
  • Mr. Bjarne Philip Tellmann (Age 56)
    Gen. Counsel
  • Ms. Tamara Rogers (Age 54)
    Chief Marketing Officer
  • Ms. Mairead Nayager (Age 48)
    Chief HR Officer
  • Mr. Bart Derde (Age 54)
    Head of Quality and Supply Chain
  • Mr. Filippo Lanzi
    Head of EMEA & LatAm
  • Ms. Teri Lyng (Age 61)
    Head of Transformation & Sustainability
  • Ms. Jooyong Lee (Age 46)
    Head of Strategy and Office of the CEO

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













HLN Stock - Frequently Asked Questions

Should I buy or sell Haleon stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLN, but not buy additional shares or sell existing shares.
View HLN analyst ratings or view top-rated stocks.

What is Haleon's stock price forecast for 2023?

9 analysts have issued twelve-month target prices for Haleon's stock. Their HLN share price forecasts range from GBX 250 to GBX 376. On average, they anticipate the company's share price to reach GBX 323.09 in the next twelve months. This suggests that the stock has a possible downside of 1.3%.
View analysts price targets for HLN or view top-rated stocks among Wall Street analysts.

How have HLN shares performed in 2023?

Haleon's stock was trading at GBX 327.35 at the beginning of the year. Since then, HLN stock has decreased by 0.0% and is now trading at GBX 327.30.
View the best growth stocks for 2023 here.

How often does Haleon pay dividends? What is the dividend yield for Haleon?

Haleon announced a dividend on Thursday, March 2nd. Stockholders of record on Thursday, March 16th will be given a dividend of GBX 2.40 per share on Thursday, April 27th. This represents a yield of 0.74%. The ex-dividend date is Thursday, March 16th. The official announcement can be seen at this link.
Read our dividend analysis for HLN.

Is Haleon a good dividend stock?

Haleon (LON:HLN) pays an annual dividend of GBX 5 per share and currently has a dividend yield of 1.49%. The dividend payout ratio is 4,545.45%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for HLN.

What is Haleon's stock symbol?

Haleon trades on the London Stock Exchange (LON) under the ticker symbol "HLN."

How do I buy shares of Haleon?

Shares of HLN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Haleon's stock price today?

One share of HLN stock can currently be purchased for approximately GBX 327.30.

How much money does Haleon make?

Haleon (LON:HLN) has a market capitalization of £30.21 billion and generates £10.86 billion in revenue each year. The company earns £1.06 billion in net income (profit) each year or GBX 0.11 on an earnings per share basis.

How can I contact Haleon?

The official website for the company is www.haleon.com. The company can be reached via phone at 44 1932 822000.

This page (LON:HLN) was last updated on 3/22/2023 by MarketBeat.com Staff